Are serum cobalt and chromium levels predictors for patient-reported outcome measures in the ASR hip resurfacing arthroplasty?

Autor:	Koper MC; Department of Orthopedics and Sports Medicine, Erasmus MC, Rotterdam, the Netherlands., Spek RWA; Department of Trauma and Orthopedic Surgery, Flinders Medical Centre, Adelaide, Australia., Reijman M; Department of Orthopedics and Sports Medicine, Erasmus MC, Rotterdam, the Netherlands., van Es EM; Department of Orthopedics and Sports Medicine, Erasmus MC, Rotterdam, the Netherlands., Baart SJ; Department of Biostatistics, Erasmus MC, Rotterdam, the Netherlands., Verhaar JAN; Department of Orthopedics and Sports Medicine, Erasmus MC, Rotterdam, the Netherlands., Bos PK; Department of Orthopedics and Sports Medicine, Erasmus MC, Rotterdam, the Netherlands.
Jazyk:	angličtina
Zdroj:	The bone & joint journal [Bone Joint J] 2023 Jul 01; Vol. 105-B (7), pp. 775-782. Date of Electronic Publication: 2023 Jul 01.
DOI:	10.1302/0301-620X.105B7.BJJ-2022-1359.R1
Abstrakt:	Aims: The aims of this study were to determine if an increasing serum cobalt (Co) and/or chromium (Cr) concentration is correlated with a decreasing Harris Hip Score (HHS) and Hip disability and Osteoarthritis Outcome Score (HOOS) in patients who received the Articular Surface Replacement (ASR) hip resurfacing arthroplasty (HRA), and to evaluate the ten-year revision rate and show if sex, inclination angle, and Co level influenced the revision rate. Methods: A total of 62 patients with an ASR-HRA were included and monitored yearly postoperatively. At follow-up, serum Co and Cr levels were measured and the HHS and the HOOS were scored. In addition, preoperative patient and implant variables and the need for revision surgery were recorded. We used a linear mixed model to relate the serum Co and Cr levels to different patient-reported outcome measures (PROMs). For the survival analyses we used the Kaplan-Meier and Cox regression model. Results: We found that an increase of one part per billion (ppb) in serum Co and Cr levels correlated significantly with worsening of the HHS in the following year. This significant correlation was also true for the HOOS-Pain and HOOS-quality of life sub scores. The overall ten-year survival rate in our cohort was 65% (95% confidence interval (CI) 52.5 to 77.6). Cox regression analysis showed a significant hazard ratio (HR) of 1.08 (95% CI 1.01 to 1.15; p = 0.028) for serum Co level. No significance was found with sex or inclination angle. Conclusion: This study shows that increasing serum Co and Cr levels measured in patients with an ASR-HRA are predictive for deterioration in HHS and HOOS subscales in the following year. Increasing serum Co and Cr should forewarn both surgeon and patient that there is a heightened risk of failure. Continued and regular review of patients with an ASR-HRA implant by measurement of serum Co/Cr levels and PROMs remains essential. Competing Interests: None declared. (© 2023 The British Editorial Society of Bone & Joint Surgery.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu